This study set out to investigate the potential targeting of ALDH1 in cisplatin resistant NSCLC using in vitro and in vivo models and to further explore CSC-mediated mechanisms of resistance. This evidence concerns the gene ALDH1A1 and non-small cell lung carcinoma.